Total | Group A (N = 29) | Group B (N = 30) | p-value |
---|---|---|---|
Cycle 1 Day 2, n (%) | 25 (86.2%) | 22 (73.3%) | 0.21974 |
Cycle 1 Day 6, n (%) | 29 (100.0%) | 29 (96.67%) | 0.3214 |
Cycle 2 Day 2, n (%) | 26 (89.7%) | 23 (76.7%) | 0.1837 |
Cycle 2 Day 6, n (%) | 29 (100.0%) | 30 (100.0%) | |
No other antiemetics | Group A (N = 20) | Group B (N = 25) | p-value |
Cycle 1 Day 2, n (%) | 17 (85.0%) | 18 (72.0%) | 0.2973 |
Cycle 1 Day 6, n (%) | 20 (100%) | 24 (96.0%) | 0.3657 |
Cycle 2 Day 2, n (%) | 18 (80.0%) | 19 (76.0%) | 0.2222 |
Cycle 2 Day 6, n (%) | 20 (100%) | 25 (100.0%) |